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Abstract
Nerve growth factor-induced gene-B (NGFI-B) is an immediate early gene first found as a part of the PC12 cell response to
NGF (Milbrandt, J., Science 238 (1987) 797^799). We have previously reported that NGFI-B mRNA is strongly upregulated
by thyroid-stimulating hormone (TSH) in dog thyrocytes in culture (Pichon et al., Endocrinology 137 (1996) 4691^4698). In
this study, we have analyzed the regulation of NGFI-B mRNA expression by a variety of agents acting on thyrocytes
proliferation and/or differentiation. We show that: (1) the induction of NGFI-B mRNA is stronger after stimulation of the
cAMP cascade, but it is not restricted to this signaling pathway; (2) the powerful mitogens for thyroid cells EGF and HGF
have little or no effect on NGFI-B mRNA induction; (3) NGFI-B mRNA is induced by anisomycin at a subinhibitory
concentration for protein synthesis, and is superinduced by the combination of TSH and anisomycin; this treatment
decreases the TSH-induced proliferation levels, but does not inhibit the induction of some differentiation markers; and (4)
both in dog and in pig thyrocytes, NGFI-B mRNA induction is observed after a variety of treatments stimulating
differentiation, but without proliferative effects. Our results therefore suggest that NGFI-B mRNA induction might not be
related to TSH-induced thyrocyte proliferation, but could participate in the differentiation program triggered by TSH.
ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Using dog thyrocytes in primary culture as a mod-
el, we have shown that the induction of NGFI-B
mRNA is an early event in the response of thyro-
cytes to TSH [1]. NGFI-B is an immediate early gene
(IEG) belonging to the nuclear receptor superfamily
of transcription factors [2]. These transcription fac-
tors bind DNA via two highly conserved zinc ¢ngers
that distinguish them from other DNA binding pro-
teins. The DNA binding speci¢city of these receptors
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is ensured by three variable amino acids located in a
region of six residues lying at the end of the ¢rst zinc
¢nger, and called the P-box [3]. NGFI-B binds DNA
as a monomer [4], and no extracellular ligand has yet
been found to regulate its trans-activation capacity
[5]. Accordingly, NGFI-B is included in the intranu-
clear monomeric orphan receptors class [6]. NGFI-B
is the prototype of this class that recognizes with
high a⁄nity the sequence AAAGGTCA, or NGFI-
B responsive element (NBRE) [4]. The AGGTCA
motif is recognized by the classical P-box. The up-
stream extension composed by two adenines is rec-
ognized by a typical seven amino acids region lying
at the end of the second zinc ¢nger and called the A-
box [4]. In addition to NGFI-B, two other members
of this class, RNR-1 [7^9] and NOR-1 [10] share the
same P- and A-boxes in their highly conserved DNA
binding domains. Consistent with this homology,
these three proteins are believed to exhibit functional
redundancy [10].
NGFI-B gene expression is controlled by several
signal transduction pathways, depending on the cell
type considered. In C2C12 myoblastic cells [11], LS-
180 colon adenocarcinoma cells [12] and T-cells [13],
the PKC cascade has been described as the main
activation pathway promoting NGFI-B induction.
A preferential activation via cAMP/PKA was already
described for the adrenocortical Y1 cells treated with
ACTH [14]. NGFI-B expression has been related, at
a functional level, with the proliferation of mouse
¢broblasts [15], the di¡erentiation of adrenocortical
cells [14] and apoptosis of T-cells [16,17]. However,
the function of this gene appears to be dependent on
the cell type and has not yet been already established
for most of them.
The functional status of the thyroid gland in mam-
mals is mainly regulated by the thyroid-stimulating
hormone, TSH. Interaction between the hormone
and speci¢c receptors located in the plasma mem-
brane of thyrocytes leads, within minutes, to in-
creased intracellular levels of cAMP (reviewed in
[18,19]). In dog thyroid cells in primary culture,
this increase in cAMP levels is responsible for the
induction of mitogenesis and for the stimulation of
the expression of thyrocyte di¡erentiation markers
(thyroglobulin, thyroperoxidase and TSH receptor)
[20]. Therefore, dog thyroid cells in primary culture
provide a well documented model for the study of
cAMP regulated cell growth and di¡erentiation [21].
In addition to TSH, dog thyrocyte proliferation can
be stimulated by TPA and several growth factors,
such as EGF and HGF. These agents inhibit the
expression of di¡erentiation characteristics. There-
fore, the growth of thyrocytes is regulated by at least
three di¡erent signaling pathways: the cAMP, PKC
and protein tyrosine kinase cascades [21]. Some of
the early events occurring after the stimulation of
the di¡erent mitogenic cascades have been recently
characterized. The proto-oncogenes c-myc, c-fos, Jun
B and Jun D are induced rapidly and transiently by
the three mitogenic pathways mentioned above
[22,23].
Depending on the species, and on the experimental
conditions, TSH is able to stimulate the di¡erentia-
tion, or both the di¡erentiation and proliferation
processes simultaneously, in thyrocytes in primary
culture. The evaluation of NGFI-B levels, as stimu-
lated by TSH, under conditions triggering either the
di¡erentiation or the proliferation programs, might
provide some clues as to the function of this early
gene in thyroid cells. Here we report a comparison of
the levels of NGFI-B mRNA expression in prolifer-
ating and di¡erentiating thyrocytes, in response to
TSH and other agents. Our results suggest that,
although not su⁄cient, NGFI-B might be necessary
for TSH induced thyrocytes di¡erentiation.
2. Materials and methods
2.1. Primary culture of dog thyroid cells
Primary cultures of dog thyroid cells were estab-
lished as previously described [24]. Cells were seeded
in 10 mm Petri dishes and cultured in a control me-
dium consisting of DMEM/Ham’s F-12/MCDB 104,
(2:1:1) (Gibco, Paisley, UK) supplemented with
1 mM sodium pyruvate, 5 Wg/ml insulin, 40 Wg/ml
ascorbic acid, 100 U/ml penicillin, 100 Wg/ml strepto-
mycin and 2.5 Wg/ml amphotericin B. They were
maintained for 4 days in the control medium, in a
water-saturated incubator at 37‡C in an atmosphere
of 5% CO2 in air. Stimulations were carried out by
addition of TSH (Armour Pharmaceutical, Chicago,
IL), forskolin (Calbiochem, San Diego, CA), TPA,
EGF, carbachol, anisomycin, cycloheximide or pur-
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omycin (Sigma, St. Louis, MO) and HGF [25,26] at
the indicated concentrations.
The activity of the tested agents was checked,
when they induce morphological changes, by phase-
contrast microscopy and the proliferation index after
the treatments was measured by the fraction of nu-
clei incorporating tritiated-thymidine [27].
2.2. RNA puri¢cation
Puri¢cation of total RNA from thyroid cells in
primary culture was carried out by scraping the cell
monolayer from the culture dishes in a 4 M guani-
dinium thiocyanate, 25 mM sodium tricitrate, 0.86 M
2-mercaptoethanol, pH 7.0 solution. Lysed cells were
carefully layered over a cushion of 5.7 M cesium
chloride, 0.1 mM EDTA, pH 7.0 in a SW 55 tube
and centrifuged at 36 000 rpm at 15‡C, 17 h, using a
SW 55 Ti rotor. Total RNA was extracted as de-
scribed by Chirgwin et al. [28]. The pellet was resus-
pended in 0.3 M NaCl, 0.1% SDS containing 60 Wg/
ml proteinase K and further puri¢ed by three con-
secutive extractions with phenol, chloroform and
ether. Finally, the RNA was precipitated with etha-
nol and resuspended in water for spectrophotometric
quantitation.
2.3. Northern-blot analysis
After 1 h denaturation at 55‡C with glyoxal and
DMSO, according to McMaster and Carmichael
[29], identical amounts of total RNA (10 Wg) were
fractionated by electrophoresis on a 1.5% agarose gel
in 10 mM phosphate bu¡er, pH 7.0. Acridine orange
staining of the gel before blotting ascertained that
the amounts of RNA loaded were equivalent in all
samples. Denatured RNAs were transferred by di¡u-
sion blotting to a positively charged nylon membrane
(Pall Biodyne B) using 20USSC (3 M NaCl, 0.3 M
sodium citrate) as described [30]. Prehybridization (4
h at 42‡C) and hybridization (overnight at 42‡C)
were carried out in 50% formamide, 5UDenhardt’s
solution (0.1% Ficoll, 0.1% polyvinylpyrrolidone),
5USSPE (0.9 M NaCl, 0.05 M sodium phosphate,
5 mM EDTA, pH 8.3), 0.3% SDS, 250 Wg/ml dena-
tured herring sperm DNA, and 200 Wg/ml bovine
serum albumin. The hybridization solution also con-
tained 10% dextran sulfate (w/v) and the heat dena-
tured probes (dog NGFI-B cDNA, 1.1 kb BamHI^
BglII insert of a pBS construct [1], dog Tg cDNA,
1.1 kb PstI insert of a pBS construct [20], or dog
TSH-R cDNA, 2.3 kb XhoI^BamHI insert of a
pSVL construct [20]) K-32P-labeled by random prim-
ing extension to a speci¢c activity of approximately
109 cpm/Wg [31]. Filters were washed four times for
10 min in 2USSC, 0.1% SDS at room temperature
and four times for 20 min in 0.1USSC, 0.1% SDS at
55‡C. They were then autoradiographed at 370‡C
using Hyper¢lm MP (Amersham) and Siemens inten-
sifying screens.
All the experiments were carried out at least twice,
with triplicates of cell Petri dishes in each treatment
(for culture experiments) and duplicates of samples
for each treatment.
2.4. RNase H treatment
A 500 pmol amount of an 18 mer oligo(dT) (syn-
thesized on an Applied Biosystems 381 A DNA syn-
thesizer) were hybridized to 15 Wg of total RNA from
control and TSH treated thyroid cells, according to
Alcivar et al. [32] and Sherman et al. [33]. The oli-
go(dT)-(A) hybrids obtained were digested with
RNase H (2 U/50 Wl reaction mixture) in a 10 mM
MgCl2, 100 mM KCl, 0.1 mM EDTA, 0.1 mM DTT,
20 mM Tris-HCl, pH 7.5 solution, for 30 min at
37‡C. The RNA was extracted once with phenol
and then with chloroform, precipitated with ethanol
at 320‡C and analyzed by Northern blotting, as de-
scribed above.
2.5. [35S]Methionine labeling of thyroid cells in
primary culture
Quiescent cells were seeded and treated with ani-
somycin (25 ng/ml or 10 Wg/ml), cycloheximide (10
Wg/ml) or puromycin (10 Wg/ml). Five minutes after
the addition of these drugs to the medium, 50 WCi/ml
[35S]methionine (Amersham) was added and after 55
min cells were washed twice with BME (Gibco). Cells
were scraped in 120 Wl of lysis bu¡er (10% glycerol,
100 mM DTT, 2% SDS in 6 mM Tris-HCl, pH 6.8).
Cell lysates were boiled for 5 min and 5 Wl of the
aliquots were precipitated using 5% TCA (two
times), washed once with methanol, ether and meth-
anol/ether/chloroform (2:2:1). The pellets were dried
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in a speed-vac and solubilized with 500 Wl of soluene
by strongly shaking. [35S]Methionine incorporated
into proteins was determined by counting the solubi-
lized samples in the presence of scintillation cocktail.
Cell lysates were also used for total protein con-
tent determination. The extracts were precipitated
with 5% TCA and pellets were washed ¢rst with
2% TCA followed by ice-cold acetone. Pellets were
resuspended in 1% SDS and protein determination
was performed using the BCA assay (Pierce).
2.6. Proliferation index measurements
DNA synthesis, or more precisely, the fraction of
cells entering into S phase, was estimated by the
frequency of [3H]thymidine-labeled nuclei by autora-
diography. After a ¢rst incubation in complete me-
dium for 24 h, the medium was supplemented with
3U1035 M thymidine, 1034 M deoxycytidine and 10
WCi/ml [3H]thymidine, and the cells were further in-
cubated for 24 h under the usual cell culture condi-
tions. The medium was then removed, and the cells
were ¢xed with methanol for 2 min and washed once
with methanol, and once with distilled water. Auto-
radiography was performed as previously described
[27], directly in the Petri dishes. After autoradiogra-
phy, cells were stained with Toluidine blue, and the
proportion of labeled nuclei was determined by
counting at least 1000 nuclei per dish.
3. Results
3.1. NGFI-B mRNA expression is di¡erentially
regulated by a variety of mitogenic agents
The kinetics of induction of NGFI-B mRNA by
six agents of di¡erent mitogenic potential, HGF,
EGF, carbachol, TPA, forskolin and TSH were com-
pared. HGF is a potent mitogen for thyroid cells
acting through the tyrosine kinase receptor encoded
by the met proto-oncogene [34]. The muscarinic ag-
onist carbachol is a non-mitogenic agent that triggers
the dog thyrocyte Ca2 phosphatidylinositol cascade
and strongly activates PKC [35]. Northern blots were
carried out using total RNA extracted from dog thy-
rocytes in primary culture, after di¡erent times of
stimulation with saturating doses of these agents.
The levels of NGFI-B mRNA were determined by
hybridization to the homologous NGFI-B cDNA
probe. Fig. 1 shows that the levels of NGFI-B
mRNA were undetectable in basal conditions.
HGF, carbachol TPA, forskolin and TSH all pro-
moted a transient expression of NGFI-B, but the
Fig. 1. NGFI-B mRNA expression in dog thyroid cells in primary culture. Thyrocytes were treated at day 4 after seeding with 50 ng/
ml HGF, 1035 M carbachol (CB), 10 ng/ml TPA, 1035 M forskolin (F) or 1 mU/ml TSH for the times shown (C, control). Total
RNA was extracted and 10 Wg/lane were electrophoresed, blotted and hybridized with the speci¢c dog NGFI-B cDNA probe, as de-
scribed in Section 2. The membrane was exposed for 3 days. Acridine orange staining of the gel before blotting is also shown.
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maximal levels of NGFI-B transcript were very dif-
ferent in each case. HGF (50 ng/ml), the most potent
mitogenic agent for dog thyroid cells in primary cul-
ture, led to an almost undetectable induction of
NGFI-B mRNA, comparable to that reached after
treatment with 25 ng/ml EGF (not shown). On the
other hand, carbachol (1035 M) caused a strong ex-
pression of NGFI-B mRNA. The induction was
early and transient, with maximal levels of the tran-
script 1 h after addition of the agent. Moreover, two
transcripts of di¡erent size, corresponding to 2.7 and
2.6 kb, were sequentially observed after carbachol
treatment. The early and transient activation, as
well as the sequential appearance of two transcripts
Fig. 2. Di¡erential activation of dog NGFI-B mRNA by inhibitors of protein synthesis. Superinduction of NGFI-B mRNA by TSH
and anisomycin. (A) Thyroid cells in primary culture were treated at day 4 after seeding for 4 h with anisomycin at subinhibitory con-
centration for protein synthesis (25 ng/ml, a), and with anisomycin, cycloheximide and puromycin at an inhibitory concentration for
protein synthesis (10 Wg/ml, A, CX and P, respectively). C, control untreated cells. (B) Thyroid cells in primary culture were stimu-
lated 4 days after seeding for 2 h with the following agents: HGF (50 ng/ml), EGF (25 ng/ml), carbachol (CB, 1035 M), TPA (10 ng/
ml), forskolin (F, 1035 M), TSH (1 mU/ml), anisomycin (25 ng/ml) and a combination of TSH and anisomycin, where the antibiotic
was added to the cells 10 min before the addition of the hormone. C, control untreated cells. Both in (A) and (B), total RNA was ex-
tracted and 10 Wg/lane were electrophoresed, blotted and hybridized with the NGFI-B probe. The blots were exposed for 5 days (A)
and 3 days (B) and developed under standard procedures.
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of di¡erent size, were similar to those obtained after
TPA (10 ng/ml), forskolin (1035 M) or TSH (1 mU/
ml) treatment [1]. These results point out that, at
least in dog thyrocytes, NGFI-B transcription is
not absolutely dependent on cAMP, since both
TPA and carbachol are able to promote an early
induction of the gene. The levels of the transcript
induced by these agents are, however, lower than
those observed in response to the physiological thy-
roid activator TSH and particularly to its functional
analog, forskolin.
Table 1 summarizes the proliferation indexes of
dog thyroid cells, after treatment with the mitogenic
agents tested above. The known ability of these
agents to promote thyrocyte di¡erentiation, and their
relative potencies as NGFI-B mRNA inducers are
also shown. As can be seen, there is no correlation
between the levels of NGFI-B mRNA induction and
the triggering of DNA synthesis.
3.2. Regulation of NGFI-B and di¡erentiation
markers mRNA expression by TSH in the
presence of protein synthesis inhibitors
Several protein synthesis inhibitors have been
shown to activate the transcription of a variety of
IEGs [36]. Moreover, the combination of growth fac-
tors and translational inhibitors results in an in-
creased and prolonged accumulation of IEG
mRNAs, a process known as superinduction
[36,37]. Therefore, the e¡ects of several protein syn-
thesis inhibitors on NGFI-B mRNA expression were
analyzed. Fig. 2A shows that among the inhibitors
tested, anisomycin produced a marked NGFI-B
mRNA induction, both at subinhibitory (25 ng/ml)
and inhibitory (10 Wg/ml) concentrations for protein
synthesis. Conversely, neither cycloheximide, nor
puromycin, used at an inhibitory concentration of
10 Wg/ml, were able to increase NGFI-B mRNA lev-
els at the times shown. The e¡ects of these protein
synthesis inhibitors at the concentrations tested on
[35S]methionine incorporation into proteins are
shown in Table 2. The di¡erence of e¡ect of aniso-
mycin, on the one hand, and puromycin and cyclo-
heximide, on the other, does not appear to be related
to slightly di¡erent degrees of ¢nal protein synthesis
inhibition. In fact, anisomycin at subinhibitory con-
centrations was already activatory, and at 10 Wg/ml
the degree of protein synthesis inhibition was very
similar, if not identical, within the experimental er-
Table 2
E¡ect of protein synthesis inhibitors on the incorporation of




Anisomycin (25 ng/ml) 20760
Anisomycin (10 Wg/ml) 7000
Cycloheximide (10 Wg/ml) 2520
Puromycin (10 Wg/ml) 5850
Thyroid cells in primary culture were treated with the antibiotic
speci¢ed at the indicated concentrations for 1 h. Five minutes
after stimulation, 50 WCi/ml [35S]methionine was added to the
cells. The cells were harvested and processed as detailed in Sec-
tion 2.
Table 1
Relationship between NGFI-B mRNA expression, cell proliferation and expression of thyroid-speci¢c genes in cultured dog thyroid
cells
Dog thyroid cells Labeling index (%) Speci¢c gene expression (Tg and TSH-R mRNA) NGFI-B mRNA
Control 1.4 basal basal
TSH (1 mU/ml) 38 +++ +++
Forskolin (1035 M) 27 +++ +++
TPA (10 ng/ml) 38 3 ++
Carbachol (1035 M) 1.5 3 ++
EGF (25 ng/ml) 21 3 +
HGF (50 ng/ml) 81 3 +
The labeling indexes are expressed as percentage of [3H]thymidine-labeled nuclei, with respect to total nuclei, after 24 h of treatment
with the di¡erent agents, in the presence of insulin for dog thyroid cells. The ability to induce speci¢c gene expression as well as to
upregulate NGFI-B mRNA is also shown.
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ror, for anisomycin and puromycin. Yet this latter
was unable to stimulate NGFI-B gene expression.
To study the induction of NGFI-B mRNA by
TSH, in the presence of a protein synthesis inhibitor,
a subinhibitory concentration of anisomycin (25 ng/
ml) was selected. Fig. 2B shows that treatment with
TSH of dog thyroid cells, for 2 h, in the presence of
anisomycin, resulted in a superinduction of NGFI-B
mRNA. In addition, a decrease of the TSH induced
proliferation rates was found when the combination
of TSH and anisomycin was used (from 38% with
TSH to 28% with TSH and anisomycin). As ex-
pected, anisomycin treatment of thyroid cells did
not have any e¡ect on the proliferation indexes.
Taking advantage of the observation that NGFI-B
mRNA was induced by anisomycin at concentrations
compatible with protein synthesis, and therefore al-
lowing for the expression of secondary genes, the
e¡ect of anisomycin on the TSH-induced mRNA ex-
pression of two thyrocyte di¡erentiation markers, Tg
and TSH-R, was analyzed, as related to NGFI-B
induction. We tested if treatment of dog thyrocytes
with TSH and subinhibitory concentrations of aniso-
mycin still promoted an accumulation of the TSH-
induced Tg and TSH-R mRNA levels. Fig. 3 shows
that Tg and TSH-R mRNA levels were enhanced
after treatment of thyroid cells with TSH, as ex-
pected. The combination of the hormone and the
Fig. 3. Induction of Tg and TSH-R mRNA by TSH and anisomycin. (A) Thyroid cells in primary culture were stimulated with TSH
(1 mU/ml), anisomycin (25 ng/ml) or a combination of both agents for 18 h. Cells were treated also with the dedi¡erentiating agents
HGF (50 ng/ml), EGF (25 ng/ml), carbachol (CB, 1035 M) and TPA (10 ng/ml), for 18 h. C, control untreated cells. Total RNA was
extracted and 10 Wg/lane of each condition were electrophoresed, blotted and hybridized with a Tg probe. The blot was developed
after 24 h exposure. (B) Northern blotting analysis of 10 Wg total RNA of the same treatments described in (A), after 2 and 18 h,
and hybridization with a dog TSH-R probe. The membrane was exposed overnight. Acridine orange staining of the gels before blot-
ting are also shown.
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antibiotic resulted in a sequential superinduction of
NGFI-B (Fig. 2B) followed by the induction of Tg
mRNA (Fig. 3A). TSH-R mRNA also increased no-
ticeably after 18 h of treatment with the combination
of TSH and anisomycin (Fig. 3B). The sequential
appearance of NGFI-B mRNA and the di¡erentia-
tion markers Tg and TSH-R mRNA was similar to
the one found when the cells were treated with TSH
alone. On the other hand, this combined treatment
slightly inhibited the stimulatory e¡ect of TSH on
the proliferation index. As a negative control for
Tg and TSH-R expression, the results after treatment
with EGF, HGF, CB and TPA are also shown in
Fig. 3A,B.
3.3. NGFI-B mRNA regulation by TSH in dog
thyrocytes cultured in the absence of insulin
In the absence of insulin, TSH treatment is not
mitogenic for dog thyrocytes in primary culture,
whereas the di¡erentiating e¡ect of the hormone is
preserved [21]. Therefore, dog thyroid cells were
grown in the presence or absence of insulin (5 Wg/
ml). Four days after seeding, the cultures were stimu-
lated with 1 mU/ml of TSH, for 1^4 h. Total RNA
was extracted at selected times and probed for
NGFI-B mRNA. As shown in Fig. 4, TSH treatment
resulted in a strong induction of NGFI-B, in the
presence and in the absence of insulin. However,
slightly faster kinetics seem to be observed in the
absence of insulin (maximum after 1 h, Fig. 4). No
e¡ect was found on NGFI-B mRNA levels when
insulin alone was tested (not shown). As expected,
the proliferation indexes in the presence of TSH
and the absence of insulin were comparable to the
controls (around 10%), whereas, in the presence of
insulin and TSH, as many as 40% of the nuclei were
found labeled.
3.4. Regulation by TSH of NGFI-B expression in pig
thyrocytes
Previous studies have shown that, under our cul-
ture conditions, TSH stimulates the expression of
di¡erentiation markers in porcine follicular cells,
but has no e¡ect on their growth [38,39]. Therefore,
the e¡ects of TSH on the levels of NGFI-B mRNA
in pig thyrocytes in culture were studied. Pig thyroid
Fig. 4. Kinetics of dog NGFI-B mRNA induced by TSH in the presence and the absence of insulin. Dog thyroid cells in primary cul-
ture were seeded both in the presence and the absence of insulin. At day 4 after seeding, they were treated with 1 mU/ml of TSH for
the times shown (C, control). Total RNA was extracted and 10 Wg/lane were analyzed by Northern blotting and hybridized with the
dog NGFI-B probe. The membrane was exposed for 2 days. Acridine orange staining of the gel before blotting is also shown.
BBAMCR 14338 17-7-98
C. Jime¤nez-Cervantes et al. / Biochimica et Biophysica Acta 1403 (1998) 232^244 239
cells in primary culture were stimulated with TSH (1
mU/ml) in the absence and the presence of insulin.
We found that pig NGFI-B mRNA was transiently
induced after TSH treatment, both in the presence
and in the absence of insulin (Fig. 5A). As in dog
thyrocytes, the kinetics were faster again in the ab-
sence of insulin. Insulin by itself promoted little, if
any, detectable accumulation of NGFI-B mRNA.
On the other hand, as for dog thyrocytes [1], a se-
quential appearance of several transcripts of di¡erent
size were found. The larger transcript appeared ear-
lier, whereas the smaller one was more evident 2 h
after the addition of TSH. The relative amounts of
these transcripts were also slightly modulated by the
presence of insulin.
The relationship between the di¡erent transcripts
found in pig thyrocytes upon TSH stimulation was
further analyzed. Total RNA extracted from TSH-
treated cells was hybridized to an oligo(dT) probe
and treated with RNase H. As shown in Fig. 5B,
after enzymatic treatment, only the smaller transcript
could be detected as a result of a shift in the electro-
phoretic mobility of the longer species. Therefore, as
for dog NGFI-B mRNAs, the smaller transcript
Fig. 5. Kinetics of activation of pig NGFI-B mRNA in pig thyroid cells in primary culture. Pig thyroid cells were seeded as described
in Section 2, and cultured both in the presence and the absence of insulin. Four days after seeding, cells were treated with 1 mU/ml
of TSH and with 5 Wg/ml insulin for the indicated times. (A) 5 Wg/lane of total RNA was analyzed by Northern blotting and hybri-
dized with the dog NGFI-B probe. The membrane was exposed for 3 days. C, control. Acridine orange staining of the gel before blot-
ting is also shown. (B) Analysis of the NGFI-B transcripts by RNase H treatment. Total RNA obtained from thyrocytes stimulated
in the presence of 1 mU/ml TSH for the indicated times was hybridized with oligo(dT) and treated with RNase H (see Section 2).
The resulting RNA was electrophoresed, in parallel with undigested samples, blotted and hybridized with the NGFI-B probe.
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most probably arises from the partial removal of a
polyA tail from the longer transcript, likely as a ¢rst
step in its degradation [40,41].
The proliferation indexes of pig thyroid cells in
primary culture, measured in the presence and the
absence of insulin, and under experimental condi-
tions identical to those employed for RNA analysis,
are shown in Table 3. It can be seen that pig cells
remained quiescent under these conditions, thus
proving that pig NGFI-B mRNA expression is not
followed by TSH-induced mitogenesis.
4. Discussion
We have previously shown that NGFI-B mRNA
expression in dog thyrocytes is strongly upregulated
by TSH and forskolin, two agents stimulating both
the proliferation and the di¡erentiation of thyrocytes
[1]. NGFI-B is less strongly upregulated by TPA,
while EGF only mediates a very slight increase in
NGFI-B mRNA. This preliminary evidence, showing
that the transcription of the NGFI-B gene in dog
thyrocytes is not absolutely dependent on cAMP,
was further strengthened by our observation that
carbachol is able to increase NGFI-B mRNA levels,
probably through a stimulation of PKC. Current
knowledge on the structure of the promoter region
of NGFI-B gene is consistent with the ¢ndings that
several signal transduction pathways are involved in
the control of NGFI-B expression. Uemura and cow-
orkers have very recently reported the sequence of
the promoter region of human NGFI-B (TR3) [42].
By cloning and sequencing the 2.3 kb 5P-£anking
region of the human TR3 gene, they demonstrated
the presence of several potential cis-acting elements,
such as one cAMP response element, ¢ve AP-1 bind-
ing site-like sequences, and one AP-2 motif. More-
over, they compared the sequences of the human, rat
and mouse NGFI-B promoter regions, and found
them to be highly conserved. A similar complexity
for the dog gene, consistent with our results, can
therefore be expected. In any case, the strongest
NGFI-B mRNA induction was observed for the
cAMP-stimulating agents, TSH and forskolin. This
suggests that the induction of NGFI-B might be an
important and early event in the proliferation and/or
di¡erentiation programs triggered by TSH, through
activation of the cAMP cascade. To further de¢ne
the role of NGFI-B in the control of the functional
status of thyrocytes, we have examined the levels of
mRNA expression after a variety of treatments with
known e¡ects on thyrocyte proliferation and di¡er-
entiation.
The agents tested for their e¡ect on the levels of
NGFI-B in thyroid cells in primary culture can be
classi¢ed in three groups: (1) protein tyrosine kinase
receptors-coupled growth factors such as HGF and
EGF, that present a powerful mitogenic activity in
our system [34]. Both HGF and EGF inhibit the
expression of di¡erentiation characteristics, since
they markedly decrease TSH-R, TPO and Tg
mRNA expression, as well as TSH-stimulated iodide
uptake [34]. They have no e¡ect on basal cAMP
levels but, conversely, induce a rapid phosphoryla-
tion of some MAPK [34]; (2) the PKC-stimulating
agents TPA and carbachol. The tumor promoter
TPA, is a strong mitogenic agent for thyroid cells
in culture. Carbachol, although non-mitogenic for
thyroid cells, triggers the Ca2-phosphatidylinositol
cascade and also stimulates PKC [35]. Like EGF
and HGF, TPA inhibits the expression of di¡eren-
tiation [35]; and (3) TSH and forskolin, that stim-
ulate both proliferation and di¡erentiation [21],
Table 3
Relation between proliferation, di¡erentiation and NGFI-B mRNA expression in pig thyroid cells in culture
Pig thyroid cells Labeling index Speci¢c gene expression NGFI-B mRNA
Control (3insulin) 5.2 basal +
TSH, 1 mU/ml (3insulin) 4.5 +++ +++
Control (+insulin) 9.8 basal +
TSH, 1 mU/ml (+insulin) 13.2 +++ +++
The labeling indexes are expressed as percentage of [3H]thymidine-labeled nuclei of pig thyroid cells treated with TSH (1 mU/ml) in
the presence and the absence of insulin (5 Wg/ml). The ability to induce speci¢c gene expression as well as to upregulate NGFI-B
mRNA is also shown.
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through activation of the adenylate cyclase-cAMP
cascade.
The induction of NGFI-B mRNA was especially
weak for the growth factors of the ¢rst group, HGF
and EGF. The fact that there is very little, if any,
induction of NGFI-B mRNA when proliferation is
induced by these powerful mitogens, suggests that, in
this case, there is no correlation between accumula-
tion of NGFI-B mRNA and mitogenesis. Therefore,
NGFI-B expression does not appear to be a neces-
sary requisite for thyrocyte proliferation triggered by
this pathway. On the other hand, we have also
shown that NGFI-B mRNA is induced by carbachol,
under experimental conditions that do not lead to
the proliferation of thyrocytes. Taken together, these
results suggest that NGFI-B induction is neither nec-
essary, nor su⁄cient for the proliferation of thyro-
cytes, at least when the growth stimulatory e¡ect is
mediated by the protein tyrosine kinase or the PKC
pathways.
The possible involvement of NGFI-B in the
cAMP-dependent cascade leading to TSH-induced
proliferation was next considered. It has been shown
that the mitogenic action of TSH on dog thyroid
cells in primary culture is dependent on the presence
of insulin or IGF-1 [27]. Conversely, Tg and TSH-R
mRNAs are upregulated by TSH even in the absence
of insulin [21]. Our results show that TSH upregu-
lates NGFI-B mRNA expression, to a similar extent
either in the presence or the absence of insulin.
In addition, we found that although thyrotropin
has no e¡ect on the proliferation of pig thyroid cells
in primary culture, a strong induction of NGFI-B
mRNA in cultured pig thyrocytes was observed after
TSH treatment. Therefore, NGFI-B mRNA expres-
sion is not su⁄cient to induce the proliferative re-
sponse of thyrocytes to cAMP.
The possibility that NGFI-B might be involved in
the cAMP-dependent di¡erentiation program trig-
gered by TSH or forskolin was ¢nally tested.
NGFI-B expression was increased by all treatments
leading to the induction of thyrocyte di¡erentiation
markers. The early and transient kinetics of NGFI-B
induction was consistent with a role in the regulation
of delayed response genes. This observation was par-
ticularly striking for the protein synthesis inhibitor
anisomycin. This agent was able to induce NGFI-B
either by itself or in combination with TSH. When
used alone and at concentrations subinhibitory for
protein synthesis, anisomycin still mediated an in-
crease in NGFI-B mRNA levels, but had no e¡ects
on proliferation, further supporting the lack of in-
volvement of NGFI-B in the control of thyrocyte
proliferation. When anisomycin was used at subin-
hibitory concentrations, and in combination with
TSH, a superinduction of NGFI-B mRNA expres-
sion was observed, as it has been reported for other
IEGs activated by protein synthesis inhibitors
[37,43]. This superinduction of NGFI-B mRNA
was followed by a higher increase in the levels of
Tg and TSH-R mRNAs, thus suggesting a relation-
ship between the level of expression of NGFI-B and
the one of thyrocyte di¡erentiation markers. Con-
versely, this combined treatment slightly inhibited
the stimulatory e¡ect of TSH on proliferation.
Taken together, these indirect lines of evidence
could point to the involvement of NGFI-B in the
control of several di¡erentiated functions of thyroid
cells. A similar possibility has already been tested in
other cell models [13,14]. However, NGFI-B is also
stimulated in dog thyrocytes by TPA and carbachol,
two agents that do not promote the expression of the
classical di¡erentiation markers, although they acti-
vate some speci¢c functions such as iodination [44].
Thus, although NGFI-B mRNA induction might be
a necessary step in the di¡erentiation program of
thyrocytes, it is not su⁄cient to drive the expression
of di¡erentiation markers. This situation can be ac-
counted for at least by two mechanisms. On the one
hand, the expression of the thyrocyte di¡erentiation
markers analyzed in this study might be controlled
by a combination of transcription factors, acting co-
ordinately with NGFI-B, like for example TTF1,
which has been shown to be involved in Tg, TSH-
R and TPO gene activation [45], or still unknown
TSH induced early genes. The speci¢city of the cel-
lular response to a given stimulus would therefore be
dictated by the particular set of transcriptional mod-
ulators controlled in the early steps, rather than by
the modulation of only one regulatory protein. This
is consistent with the current knowledge on the con-
trol of gene expression [46], in a variety of tissues
including the thyroid [45]. On the other hand, it
has been shown that the NGFI-B protein is phos-
phorylated at multiple sites and that both the num-
ber and the position of the amino acid residues phos-
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phorylated varies depending on the type of the reg-
ulatory stimulus [47,48]. Changes in phosphorylation
have been shown to modify the DNA binding ability
of a variety of transcription factors [49], including
NGFI-B [48]. Therefore, in addition to the types of
transcription factors activated along with NGFI-B
by a given stimulus, their di¡erential phosphoryla-
tion by kinase(s) speci¢c of each transduction path-
way might contribute to the control of the delayed
responses elicited in each case.
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